11th Circ. Undermined Rare-Disease Drugs, High Court Told
Jacobus Pharmaceutical Co. Inc. said that the Eleventh Circuit created a circuit split and upended years of U.S. Food and Drug Administration policy when it ruled lucrative exclusivity for so-called orphan...To view the full article, register now.
Already a subscriber? Click here to view full article